Log in to save to my catalogue

SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepr...

SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2513720347

SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class

About this item

Full title

SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class

Publisher

New York: Springer US

Journal title

Neurochemical research, 2021-05, Vol.46 (5), p.1252-1263

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Depression is a disabling psychiatric disorder affecting millions of people all around the world. Under current therapeutic choices, a portion of patients are not responsive, have relapses, or experience cognitive side effects. Hence, the present study aimed to find other antidepressant compounds lacking the mentioned deficiency. Since epigenetic r...

Alternative Titles

Full title

SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2513720347

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2513720347

Other Identifiers

ISSN

0364-3190

E-ISSN

1573-6903

DOI

10.1007/s11064-021-03263-8

How to access this item